Zimmer Biomet Holdings, Inc.
ZBH
Rangering i aksjer
#1247
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Aksjekurs
$94.73
Markedsverdi
$18.07B
Endring (1 dag)
-1.26%
Endring (1 år)
-7.75%
Land
US
Handel Zimmer Biomet Holdings, Inc. (ZBH)
Kategori
Healthcare
Inntekter for Zimmer Biomet Holdings, Inc. (ZBH)
Inntekter i Jun 2026 TTM: $8.51B
Ifølge de nyeste økonomiske rapportene til Zimmer Biomet Holdings, Inc. er selskapets nåværende inntekter (TTM) $8.51B. I 2024 hadde selskapet inntekter på $7.68B en økning sammenlignet med inntektene i 2023, som var $7.39B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Zimmer Biomet Holdings, Inc. fra 2000 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $8.51B | 3.37% |
| 2025 | $8.23B | 7.20% |
| 2024 | $7.68B | 3.85% |
| 2023 | $7.39B | 6.55% |
| 2022 | $6.94B | 1.65% |
| 2021 | $6.83B | 11.42% |
| 2020 | $6.13B | -23.24% |
| 2019 | $7.98B | 0.62% |
| 2018 | $7.93B | 1.66% |
| 2017 | $7.80B | 1.76% |
| 2016 | $7.67B | 27.85% |
| 2015 | $6.00B | 28.34% |
| 2014 | $4.67B | 1.08% |
| 2013 | $4.62B | 3.39% |
| 2012 | $4.47B | 0.45% |
| 2011 | $4.45B | 5.49% |
| 2010 | $4.22B | 3.05% |
| 2009 | $4.10B | -0.62% |
| 2008 | $4.12B | 5.74% |
| 2007 | $3.90B | 11.50% |
| 2006 | $3.50B | 6.37% |
| 2005 | $3.29B | 10.24% |
| 2004 | $2.98B | 56.81% |
| 2003 | $1.90B | 38.52% |
| 2002 | $1.37B | 16.44% |
| 2001 | $1.18B | 13.26% |
| 2000 | $1.04B | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $46.59B | 447.49% |
US
|
|
| $35.48B | 317.02% |
IE
|
|
| $25.84B | 203.65% |
US
|
|
| $21.00B | 146.75% |
US
|
|
| - | - |
DE
|
